NASDAQ
CLBTW

Cellebrite DI Equity Warrants

Software & IT Services
Technology

Prices are adjusted according to historical splits.

Cellebrite DI Equity Warrants Stock Price

Vitals

Today's Low:
$1.17
Today's High:
$1.21
Open Price:
$1.21
52W Low:
$0.5004
52W High:
$1.26
Prev. Close:
$1.16
Volume:
13901

Company Statistics

Market Cap.:
$0
Book Value:
0.593
Revenue TTM:
$222.86 million
Operating Margin TTM:
11.96%
Gross Profit TTM:
$0
Profit Margin:
10.08%
Return on Assets TTM:
0%
Return on Equity TTM:
0%

Company Profile

Cellebrite DI Equity Warrants had its IPO on 2020-11-03 under the ticker symbol CLBTW.

The company operates in the Technology sector and Software & IT Services industry. Cellebrite DI Equity Warrants has a staff strength of 765 employees.

Stock update

Shares of Cellebrite DI Equity Warrants opened at $1.21 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.17 - $1.21, and closed at $1.18.

This is a +1.72% increase from the previous day's closing price.

A total volume of 13,901 shares were traded at the close of the day’s session.

In the last one week, shares of Cellebrite DI Equity Warrants have slipped by -20.27%.

Cellebrite DI Equity Warrants's Key Ratios

Cellebrite DI Equity Warrants has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Cellebrite DI Equity Warrants’s revenue was $222.86 million with a gross profit of $0 and an EBITDA of $32.59 million. The EBITDA ratio measures Cellebrite DI Equity Warrants's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cellebrite DI Equity Warrants’s operating margin was 11.96% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, Cellebrite DI Equity Warrants’s quarterly earnings growth was a positive 0% while revenue growth was a positive 29.3%.

Cellebrite DI Equity Warrants’s PE and PEG Ratio

Forward PE
0
Trailing PE
15.7143
PEG

Its diluted EPS in the last 12-months stands at $0.056 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cellebrite DI Equity Warrants’s profitability.

Cellebrite DI Equity Warrants stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Cellebrite DI Equity Warrants stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$412.69 million
Total Liabilities
$204.74 million
Operating Cash Flow
$0
Capital Expenditure
$1.06 million
Dividend Payout Ratio
0%

Cellebrite DI Equity Warrants ended 2024 with $412.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $412.69 million while shareholder equity stood at $39.36 million.

Cellebrite DI Equity Warrants ended 2024 with $0 in deferred long-term liabilities, $204.74 million in other current liabilities, in common stock, $158.64 million in retained earnings and $26.83 million in goodwill. Its cash balance stood at $98.97 million and cash and short-term investments were $202.65 million. The company’s total short-term debt was $4,723,000 while long-term debt stood at $0.

Cellebrite DI Equity Warrants’s total current assets stands at $310.29 million while long-term investments were $18.52 million and short-term investments were $103.68 million. Its net receivables were $69.59 million compared to accounts payable of $4.92 million and inventory worth $11.41 million.

In 2024, Cellebrite DI Equity Warrants's operating cash flow was $0 while its capital expenditure stood at $1.06 million.

Comparatively, Cellebrite DI Equity Warrants paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$1.18
52-Week High
$1.26
52-Week Low
$0.5004
Analyst Target Price
$

Cellebrite DI Equity Warrants stock is currently trading at $1.18 per share. It touched a 52-week high of $1.26 and a 52-week low of $1.26. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $1.25 and 200-day moving average was $0.9 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Cellebrite DI Equity Warrants

The stock symbol (also called stock or share ticker) of Cellebrite DI Equity Warrants is CLBTW

The IPO of Cellebrite DI Equity Warrants took place on 2020-11-03

Similar Industry Stocks (Software & IT Services)

Last Price
Chg
Chg%
$583.35
-80.6
-12.14%
$155.25
-4.65
-2.91%
$0.1
-0.01
-8.41%
Uflex Limited (500148)
$439.6
-24.4
-5.26%
$19.94
0.01
+0.05%
$83.59
-0.15
-0.18%
$47.43
-2.48
-4.97%
AmmPower Corp (AMMPF)
$0.13
0.01
+4.42%
$1.3
-0.04
-2.99%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors worldwide. The company offers Cellebrite UFED, a platform for lawfully accessing and collecting digital data; Cellebrite physical analyzer, a digital data examiner; Cellebrite UFED Cloud, a platform that allow to collect, preserve, and analyze public and private-domain, social-media data, instant messaging, file storage, web pages, and other cloud-based content; Cellebrite Frontliner that collects digital evidence in real-time; Cellebrite Responder; and Cellebrite Premium. It also provides Cellebrite Seeker, a solution that collects, analysis, and reports video evidences; Cellebrite Digital Collector, a solution that allow to collect live and targeted computer data; Cellebrite pathfinder; Cellebrite Reader; Cellebrite Inspector, a computer data analysis solution; and Cellebrite Crypto Tracer that provides evidence against individuals use Bitcoin and other cryptocurrencies for money laundering, terrorism, drug and human trafficking, weapon sales, and other crimes. In addition, the company offers Cellebrite Endpoint Inspector; Cellebrite Commander; and Cellebrite Guardian, a SaaS solution for evidence management, sharing, and review that enables to manage evidence and investigative workflow. Further, it provides training and advisory; advanced digital data access and collection; technical workshops; solution deployment; crypto investigations; value realization; and technical customer support services. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.

Address

94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602